Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Ragab

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|June 10, 2016
Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk StratificationShane Mesko, Leonard Marks, Omar Ragab, et al.
Investigative Ophthalmology & Visual Science|May 30, 2013
Regional correlation among ganglion cell complex, nerve fiber layer, and visual field loss in glaucomaPhuc V Le, Ou Tan, Vikas Chopra, et al.
Pediatric Blood & Cancer|April 10, 2018
Acute toxicity of craniospinal irradiation with volumetric-modulated arc therapy in children with solid tumorsKenneth K Wong, Omar Ragab, Hung N Tran, et al.
Chinese Clinical Oncology|November 9, 2020
Multidisciplinary sarcoma tumor board: adolescent and young adult soft tissue sarcoma-myxoid liposarcoma and alveolar soft part sarcomaPriya Jayachandran, Dakshesh Patel, James Hu, et al.
Anticancer Research|September 6, 2017
Inflammatory Breast Cancer Outcomes in a Contemporary SeriesElizabeth Pan, Lily Tung, Omar Ragab, et al.
Journal of Medical Imaging and Radiation Oncology|September 1, 2017
Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapyOmar Ragab, Robyn Banerjee, Sang-June Park, et al.
Brachytherapy|December 7, 2024
Clinical and dosimetric outcomes of a 3-fraction high-dose-rate brachytherapy boost for the treatment of locally advanced cervical cancer in a safety net hospitalKaren Cheng, Samuel To, Zichen Liu, et al.
Brachytherapy|December 15, 2016
High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancerShyamal Patel, D Jeffrey Demanes, Omar Ragab, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2023
Knowledge and Understanding of Radiation Therapy Among Patients With Breast Cancer From Culturally Diverse Backgrounds at a Safety-Net HospitalApril Vassantachart, Omar Ragab, Kimberly Miller, et al.
Radiation Oncology (London, England)|August 26, 2021
Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgeryHeather Miller, Koji Matsuo, Lynda D Roman, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|June 10, 2016
Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk StratificationShane Mesko, Leonard Marks, Omar Ragab, et al.
Investigative Ophthalmology & Visual Science|May 30, 2013
Regional correlation among ganglion cell complex, nerve fiber layer, and visual field loss in glaucomaPhuc V Le, Ou Tan, Vikas Chopra, et al.
Pediatric Blood & Cancer|April 10, 2018
Acute toxicity of craniospinal irradiation with volumetric-modulated arc therapy in children with solid tumorsKenneth K Wong, Omar Ragab, Hung N Tran, et al.
Chinese Clinical Oncology|November 9, 2020
Multidisciplinary sarcoma tumor board: adolescent and young adult soft tissue sarcoma-myxoid liposarcoma and alveolar soft part sarcomaPriya Jayachandran, Dakshesh Patel, James Hu, et al.
Anticancer Research|September 6, 2017
Inflammatory Breast Cancer Outcomes in a Contemporary SeriesElizabeth Pan, Lily Tung, Omar Ragab, et al.
Journal of Medical Imaging and Radiation Oncology|September 1, 2017
Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapyOmar Ragab, Robyn Banerjee, Sang-June Park, et al.
Brachytherapy|December 7, 2024
Clinical and dosimetric outcomes of a 3-fraction high-dose-rate brachytherapy boost for the treatment of locally advanced cervical cancer in a safety net hospitalKaren Cheng, Samuel To, Zichen Liu, et al.
Brachytherapy|December 15, 2016
High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancerShyamal Patel, D Jeffrey Demanes, Omar Ragab, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2023
Knowledge and Understanding of Radiation Therapy Among Patients With Breast Cancer From Culturally Diverse Backgrounds at a Safety-Net HospitalApril Vassantachart, Omar Ragab, Kimberly Miller, et al.
Radiation Oncology (London, England)|August 26, 2021
Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgeryHeather Miller, Koji Matsuo, Lynda D Roman, et al.
Pageof 3